TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34271979

Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Moderate-intensity aerobic training
Number of subjects: 50
Study: 33230706

Group type: EXPERIMENTAL
Intervention: Mixture of whole rice straw (WRS), chopped rice straw (CRS), and zeolite (Z)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Treated wastewater
Number of subjects: 33
Study: 35788657

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3676
Study: 35936578

Group type: EXPERIMENTAL
Intervention: Telestroke model
Number of subjects: 22

Group type: COMPARATOR
Intervention: Stroke physician model
Number of subjects: 22
Study: 32115267

Group type: EXPERIMENTAL
Intervention: Optical coherence tomography angiography (OCTA)
Number of subjects: 651

Group type: COMPARATOR
Intervention: Fluorescein angiography (FA)
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: OCTA
Number of subjects: 651

Group type: COMPARATOR
Intervention: FA
Number of subjects: 651
Study: 32546749

Group type: EXPERIMENTAL
Intervention: Storage case with a 'no-water' sticker (test)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Storage case without a 'no-water' sticker (control)
Number of subjects: 200
Study: 34221034

Group type: EXPERIMENTAL
Intervention: Isosceles-configured SUN Teeth™ toothbrush
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard reference toothbrush with end-rounded bristles
Number of subjects: 104
Study: 32335531

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg body mass)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 35400396

Group type: EXPERIMENTAL
Intervention: Preload drink of 210 kcal
Number of subjects: 60
Study: 32119790

Group type: EXPERIMENTAL
Intervention: Control-IQ using MyTDI parameters
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control-IQ using home settings
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Control-IQ (both groups)
Number of subjects: 20
Study: 34106357

Group type: EXPERIMENTAL
Intervention: Pivotal Response Treatment (PRT)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Robot-assisted Pivotal Response Treatment (PRT + robot)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 73
Study: 33725842

Group type: EXPERIMENTAL
Intervention: Standard care plus short message service reminders (text message intervention)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 100
Study: 33165631

Group type: EXPERIMENTAL
Intervention: Robotic-assisted TKA (RA-TKA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional TKA (C-TKA)
Number of subjects: 60
Study: 33069784

Group type: EXPERIMENTAL
Intervention: Endothelial function guided treatment group
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard of care control group
Number of subjects: 1000
Study: 34064968

Group type: EXPERIMENTAL
Intervention: Baked/boiled potatoes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (basal diet of 60 mmol/d)
Number of subjects: 30
Study: 32097261

Group type: EXPERIMENTAL
Intervention: Anterior controllable antidisplacement and fusion (ACAF)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Laminoplasty
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: ACAF
Number of subjects: 80
Study: 33872825

Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs) prescribed by PCPs
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Knowledge of DOACs among PCPs
Number of subjects: 50
Study: 34191028

Group type: EXPERIMENTAL
Intervention: Daily meal with 1 fresh Hass avocado
Number of subjects: 105

Group type: COMPARATOR
Intervention: Isocaloric meal without avocado (control)
Number of subjects: 105
Study: 32871530

Group type: EXPERIMENTAL
Intervention: High-intensity light therapy (LT-5000 lux)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Low-intensity light therapy (LT-500 lux)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Waiting-list control (WLC)
Number of subjects: 142
Study: 35879524

Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 44
Study: 32810344

Group type: EXPERIMENTAL
Intervention: Small-sided games (SSG)
Number of subjects: 14
Study: 34268638

Group type: EXPERIMENTAL
Intervention: Slowness therapy (weekly speech therapy sessions with stimuli played slowly on a PC)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Real-time stimuli speech therapy (age- and level-matched control group)
Number of subjects: 23
Study: 34111616

Group type: COMPARATOR
Intervention: Xiao-Chai-Hu-Tang (XCHT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manipulation of gut bacteria (via FMT or antibiotics)
Number of subjects: 0
Study: 32125522

Group type: EXPERIMENTAL
Intervention: Music during labor
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 30
Study: 36102337

Group type: EXPERIMENTAL
Intervention: Cocoa extract (500 mg/day flavanols)
Number of subjects: 2262

Group type: EXPERIMENTAL
Intervention: Multivitamin-mineral (MVM) supplementation
Number of subjects: 2262
Study: 33159574

Group type: EXPERIMENTAL
Intervention: Vitamin K2 (menaquinone-7) 180 µg twice a day for 12 weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 32464082

Group type: EXPERIMENTAL
Intervention: FS4 strategy
Number of subjects: 12

Group type: COMPARATOR
Intervention: FSP strategy
Number of subjects: 12
Study: 33545136

Group type: EXPERIMENTAL
Intervention: EUS-guided biliary drainage (EUS-BD) using lumen-apposing metal stents
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EUS-guided biliary drainage (EUS-BD)
Number of subjects: 20
Study: 33228575

Group type: EXPERIMENTAL
Intervention: Aripiprazole (15 mg orally)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Aripiprazole (15 mg orally) with abnormally low prolactin levels
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Aripiprazole (15 mg orally) without abnormally low prolactin levels
Number of subjects: 63
Study: 35266064

Group type: EXPERIMENTAL
Intervention: Real-time operation video (Group A)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Explanation about the operation process (Group B)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Real-time operation video + Explanation about the operation process (Group C)
Number of subjects: 124

Group type: COMPARATOR
Intervention: No intervention (Group D)
Number of subjects: 124
Study: 32302504

Group type: EXPERIMENTAL
Intervention: Vitamin B12 (5 μg/day for 100 days)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard supplementation (350 mg/day ferrous iron, 5 mg folic acid)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 200
Study: 35624509

Group type: EXPERIMENTAL
Intervention: Pharmacist-led inhaler technique assessment service
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 39
Study: 33064182

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg once daily)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Interval-based exercise (5 days/week, 30 min/session)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Metformin (1700 mg daily)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (habitual lifestyle)
Number of subjects: 120
Study: 33189805

Group type: EXPERIMENTAL
Intervention: No advanced airway
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Supraglottic airway (SGA)
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Tracheal intubation
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Combination of airway strategies
Number of subjects: 2058

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 2058
Study: 33189370

Group type: EXPERIMENTAL
Intervention: Group D - 30 mL of 0.5% levobupivacaine with vasoconstrictor and 6 mg (1.5 mL) of dexamethasone
Number of subjects: 74

Group type: COMPARATOR
Intervention: Group C - 30 mL of 0.5% levobupivacaine with vasoconstrictor and 1.5 mL of 0.9% saline
Number of subjects: 74

Group type: COMPARATOR
Intervention: Group C
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Group D
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 74
Study: 35787963

Group type: COMPARATOR
Intervention: CRASH model
Number of subjects: 423
Study: 33172907

Group type: EXPERIMENTAL
Intervention: Avoidable significant harm incidents
Number of subjects: 14407

Group type: EXPERIMENTAL
Intervention: Diagnostic errors
Number of subjects: 14407

Group type: EXPERIMENTAL
Intervention: Medication-related problems
Number of subjects: 14407

Group type: EXPERIMENTAL
Intervention: Delayed referrals
Number of subjects: 14407

Group type: EXPERIMENTAL
Intervention: Actions aligned with evidence-based guidelines
Number of subjects: 14407
Study: 32674208

Group type: EXPERIMENTAL
Intervention: Relugolix (Relumina)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Leuprolide (Lupron)
Number of subjects: 0
Study: 34935191

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 33218692

Group type: EXPERIMENTAL
Intervention: Nutrition Group (NG)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual Care Group (UG)
Number of subjects: 104
Study: 34656987

Group type: EXPERIMENTAL
Intervention: SB11
Number of subjects: 705
Study: 33352474

Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Age and pubertal development influence on cortisol response
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Diagnosis by TSST timepoint interaction
Number of subjects: 241
Study: 35944003

Group type: EXPERIMENTAL
Intervention: ActTeens physical activity program
Number of subjects: 140
Study: 34628743

Group type: EXPERIMENTAL
Intervention: Moxibustion combined with Daiwenjiu plaster
Number of subjects: 240

Group type: COMPARATOR
Intervention: Conventional observation (Control)
Number of subjects: 240
Study: 34286398

Group type: EXPERIMENTAL
Intervention: Sealing with resin-modified glass-ionomer cement (RMGIC)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Restoration with resin-modified glass-ionomer cement (RMGIC)
Number of subjects: 68
Study: 33727522

Group type: EXPERIMENTAL
Intervention: 0.075 mg/kg oxycodone (Group A)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg oxycodone (Group B)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 0.125 mg/kg oxycodone (Group C)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Midazolam and 0.075 mg/kg oxycodone (Group A)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Midazolam and 0.1 mg/kg oxycodone (Group B)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Midazolam and 0.125 mg/kg oxycodone (Group C)
Number of subjects: 119
Study: 35636580

Group type: EXPERIMENTAL
Intervention: Stochastic vibratory stimulation (SVS) during device on (N)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual treatment (Phase 1)
Number of subjects: 30
Study: 32064596

Group type: EXPERIMENTAL
Intervention: Topical rapamycin 0.1%
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Topical calcitriol 0.0003%
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Topical rapamycin-calcitriol combination
Number of subjects: 52
Study: 35226053

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Oriented Recovery Enhancement (MORE)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Supportive psychotherapy (control)
Number of subjects: 250
Study: 32271151

Group type: EXPERIMENTAL
Intervention: Social group-based strategy including tutorial on exercise monitoring, encouragement to share exercise records, and assistance with activity tracker use.
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group receiving wrist-worn activity trackers and instructions without additional intervention.
Number of subjects: 149
Study: 35294537

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg orally twice daily for 10 days
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study: 33077124

Group type: EXPERIMENTAL
Intervention: Post-exercise passive-heating condition (suit worn for 1 hour after 1-hour walking)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Passive-heating condition (suit worn for 2 hours)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Exercise-only condition (1-hour treadmill walking followed by 1-hour rest)
Number of subjects: 19
Study: 34298398

Group type: EXPERIMENTAL
Intervention: ω-3 polyunsaturated fatty acid treatment
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: General treatment
Number of subjects: 126

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 126
Study: 32502876

Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (1.8 mg/kg once every 3 weeks; ≤16 cycles)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physician's choice (methotrexate/bexarotene; ≤48 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physician's choice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (in patients with peripheral neuropathy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (in patients without peripheral neuropathy)
Number of subjects: 0
Study: 37150125

Group type: EXPERIMENTAL
Intervention: Probiotic capsules (Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Indole-3-propionic acid (IPA) (5 μM) in vitro
Number of subjects: 63
Study: 33068425

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine once-weekly (400 mg)
Number of subjects: 1483

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine twice-weekly (400 mg)
Number of subjects: 1483

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1483
Study: 32143727

Group type: COMPARATOR
Intervention: Gyejibongnyeong-Hwan
Number of subjects: 0
Study: 36075892

Group type: EXPERIMENTAL
Intervention: PRS‐PGx‐Bayes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other PRS‐PGx methods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Disease PRS methods
Number of subjects: 0
Study: 33814437

Group type: EXPERIMENTAL
Intervention: β-lactolin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 34275797

Group type: EXPERIMENTAL
Intervention: Gefitinib ± cisplatin ± pemetrexed
Number of subjects: 115

Group type: COMPARATOR
Intervention: Cisplatin ± pemetrexed
Number of subjects: 115
Study: 35947252

Group type: EXPERIMENTAL
Intervention: First batch of mydriasis
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Second batch of mydriasis (5 hours later)
Number of subjects: 30
Study: 32453167

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA) ventilation
Number of subjects: 77

Group type: COMPARATOR
Intervention: Rigid bronchoscope ventilation
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: LMA ventilation
Number of subjects: 77
Study: 35897037

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (5 billion colony-forming units/day for 6 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 36069596

Group type: EXPERIMENTAL
Intervention: Intravenous iron repletion (one-gram low molecular weight iron dextran)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Intravenous iron repletion
Number of subjects: 79
Study: 33629326

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control intervention (placebo or nothing)
Number of subjects: 12
Study: 32525564

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) during cisplatin-based chemotherapy (CBCT) for testicular cancer (TC). The intervention included two weekly HIIT sessions, each with 2 to 4 intervals of 2 to 4 minutes at 85% to 95% of peak heart rate for 9 to 12 weeks.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Single lifestyle counseling session (control group).
Number of subjects: 19
Study: 34978859

Group type: EXPERIMENTAL
Intervention: Intensive AF screening with an implantable loop recorder
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34296794

Group type: EXPERIMENTAL
Intervention: Evolved isolates of B. subtilis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mix of evolved isolates
Number of subjects: 0
Study: 35031139

Group type: EXPERIMENTAL
Intervention: Targeted sampling (TS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Systematic sampling (SS)
Number of subjects: 38
Study: 33547330

Group type: EXPERIMENTAL
Intervention: Adjuvant exemestane for 5 years
Number of subjects: 807
Study: 36064672

Group type: EXPERIMENTAL
Intervention: Vi-DT + MMR
Number of subjects: 360

Group type: COMPARATOR
Intervention: MMR alone
Number of subjects: 360
Study: 34152632

Group type: EXPERIMENTAL
Intervention: Hemoadsorption (HA) therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 35192543

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCov-19 (AZD1222) vaccination
Number of subjects: 54
Study: 33932814

Group type: EXPERIMENTAL
Intervention: Sleep-based intervention
Number of subjects: 165
Study: 32858523

Group type: EXPERIMENTAL
Intervention: After-school intervention (structured physical activity and academic enrichment activities for 2.5 hours, 3 afternoons per week for 6 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (usual after-school care practice)
Number of subjects: 60
Study: 36263928

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Insulin degludec 100 U/mL (IDeg-100)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300) and Insulin degludec 100 U/mL (IDeg-100)
Number of subjects: 343
Study: 34519665

Group type: EXPERIMENTAL
Intervention: mHealth intervention (digitally delivered via a smartphone app)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual care (standard multidisciplinary care)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: mHealth intervention
Number of subjects: 109
Study: 35417762

Group type: EXPERIMENTAL
Intervention: Conventional plus Fluciclovine (18F) PET (arm 2)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Conventional only (arm 1)
Number of subjects: 165
Study: 33278503

Group type: EXPERIMENTAL
Intervention: Low-dose whole-lung irradiation (LD-WLI) 0.5 Gy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-dose whole-lung irradiation (LD-WLI) 1.0 Gy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-dose whole-lung irradiation (LD-WLI) overall
Number of subjects: 10
Study: 35105383

Group type: EXPERIMENTAL
Intervention: Settled accommodation (Private Rented Sector, Social Housing, Housing First)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Temporary accommodation (control group)
Number of subjects: 150
Study: 33465795

Group type: EXPERIMENTAL
Intervention: Melissa Officinalis L. (500 mg daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Citalopram (30 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32164522

Group type: EXPERIMENTAL
Intervention: Choline supplementation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 36121830

Group type: EXPERIMENTAL
Intervention: Systematic medication review conducted by pharmacists during the emergency department stay
Number of subjects: 789

Group type: COMPARATOR
Intervention: Standard care from emergency department physicians and nurses
Number of subjects: 789
Study: 34893523

Group type: EXPERIMENTAL
Intervention: Andecaliximab (ADX) plus Nivolumab (NIVO)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Nivolumab (NIVO) alone
Number of subjects: 144
Study: 33579359

Group type: EXPERIMENTAL
Intervention: Rapid micro-induction of buprenorphine/naloxone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard induction of buprenorphine/naloxone
Number of subjects: 50
Study: 36396490

Group type: EXPERIMENTAL
Intervention: Flat occlusal scheme with feather-edge finish line (FF)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Flat occlusal scheme with rounded shoulder finish line (FS)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Planar occlusal scheme with rounded shoulder finish line (PS)
Number of subjects: 66
Study: 35278124

Group type: EXPERIMENTAL
Intervention: 150 mg etifoxine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.5 mg alprazolam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32663382

Group type: EXPERIMENTAL
Intervention: Online self-help program (Hands-off)
Number of subjects: 242
Study: 35760153

Group type: EXPERIMENTAL
Intervention: a‐tDCS
Number of subjects: 40

Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 40
Study: 33624122

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) provided by primary care nurses (n = 50)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) provided by urogynaecology nurse specialist (n = 53)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Comparison between primary care nurse and urogynaecology nurse specialist groups
Number of subjects: 240
Study: 35710124

Group type: EXPERIMENTAL
Intervention: Guided internet based cognitive behavioural therapy (CBT‐TF) with an eight step online programme, up to three hours of contact with a therapist, and four brief telephone calls or email contacts between sessions.
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Guided internet based cognitive behavioural therapy (CBT‐TF)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Individual face‐to‐face cognitive behavioural therapy (CBT‐TF)
Number of subjects: 196
Study: 32313779

Group type: EXPERIMENTAL
Intervention: Excision and primary closure (Group A, n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bascom's technique (Group B, n=30)
Number of subjects: 60
Study: 36462425

Group type: EXPERIMENTAL
Intervention: Classrooms with more classmates experiencing early childhood health shocks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classrooms with fewer classmates experiencing early childhood health shocks
Number of subjects: 0